Joint replacement devices are intended for the restoration or substitution of damaged joints including knees, hips, shoulders, ankles, and elbows. The medical devices are used to treat joint disease such as osteoarthritis, rheumatoid arthritis, traumatic injuries, and congenital joint deformities relies heavily on these medical devices. The market is driven by rising prevalence of joint diseases, advancement in surgical techniques, advancement in implant materials and others. Patient inclination towards less invasive treatments combined with the expanding deployment of robotic and image-assisted surgical techniques drives adoption rates.
In line with the adoption rate, the global joint reconstruction devices market stood at US$ 19,852.46 million in 2024 and is expected to reach US$ 30,573.75 million by 2033. The financial burden of implants and medical procedures combined with strict regulatory hurdles and potential complications or implant failures present major obstacles. The availability of quality healthcare services remains restricted in economically disadvantaged areas. The potential for future development encompasses expansion within emerging markets alongside the increased adoption of 3D-printed personalized implants and smart sensor technologies which aim to improve post-operative results and long-term implant functionality.
You can easily get a sample PDF of the report – https://www.businessmarketinsights.com/sample/BMIPUB00031715
Joint Reconstruction Devices Market Segmentation Analysis
Key segments that contributed to the derivation of the joint reconstruction devices market analysis are product type, fixation type, material type, surgery type and end user.
- By product type, the joint reconstruction devices market is segmented into knee reconstruction devices, hip reconstruction devices, shoulder reconstruction devices, elbow reconstruction devices, others. The knee reconstruction devices segment dominated the market in 2024.
- By fixation type, the joint reconstruction devices market is segmented into cemented, cementless, and hybrid. The cemented segment dominated the market in 2024.
- By material type, the market is segmented into metal, ceramic and polymer. The metal segment held the largest share of the market in 2024.
- By surgery type, the market is segmented into total replacement, partial replacement, and revision. The total replacement segment held the largest share of the market in 2024.
- By end user, the market is segmented into hospitals, ambulatory surgical centers, and orthopedic clinics. The hospitals segment held the largest share of the market in 2024.
Joint Reconstruction Devices Market Drivers and Opportunities:
Rising Osteoarthritis Cases
Healthcare systems face mounting pressures due to a global increase in life expectancy which results in more age-related health conditions. Musculoskeletal disorders emerge as a common disease which severely affects both mobility and quality of life. The frequency of degenerative joint diseases has increased among aging populations particularly in developed and fast-developing countries.
Among older adults, osteoarthritis stands as the predominant arthritis type that leads to joint deterioration and disability. The knee, hip, and shoulder joints represent the primary regions affected which commonly undergo treatment with joint reconstruction devices. The number of osteoarthritis cases continues to rise, leading an increasing number of patients to choose joint replacement surgeries as a means to regain functionality and alleviate persistent pain.
For instance, according to an article published in September 2023 in The Lancet Rheumatology, an open-access medical journal, globally around 595 million people were suffering from osteoarthritis in 2020, which was equal to 7.6% of the global population. In addition, according to the same source, compared with 2020, cases of osteoarthritis are projected to increase 74.9% for knee, 48.6% for hand, 78.6% for hip, and 95.1% for other types of osteoarthritis by 2050. This has increased demand for technologically advanced, durable, and minimally invasive joint reconstruction solutions.
Rising Number of Joint Replacement Surgeries
The rising number of joint replacement surgeries drives demand for joint replacements surgeries for joint such as knee and hips. These are the most common orthopedic procedures performed globally. Surgical technique improvements combined with superior implant materials and expanded insurance coverage have increased both the effectiveness and accessibility of these surgeries.
For instance, according to the report published in September 2024 by American Association of Hip and Knee Surgeons (AAHKS), the total number of hip replacement procedures in U.S. were 763,691 in 2022 which increased to 793,082 in 2023, marking a 3.8% growth. Similarly, knee surgeries experienced an even stronger upward trend, with the total number increasing from 1,293,438 in 2022 to 1,359,110 in 2023, a 5.1% jump.
The increasing number of surgical operations generates high demand for joint reconstruction devices needed in both initial surgeries and subsequent procedures. The joint reconstruction devices market experiences substantial growth due to the rising frequency of joint replacement surgeries.
Joint Reconstruction Devices Market News and Key Development:
The joint reconstruction devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the joint reconstruction devices market are:
- On April 1, 2025, restor3d, a 3D-printing, personalized orthopedic implant care company, announced that they have received FDA 510(k) clearance for the iTotal Identity CR 3DP Porous Total Knee Replacement System.
- In December 2024, Zimmer Biomet, a global medical technology company, announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona SoluTion Porous Plasma Spray Femur, a total knee implant component offering an alternative for patients with sensitivities to bone cement and/or metal.
- In August 2023, Smith Nephew, the global medical technology company, announced that they have launched OR3O Dual Mobility System for use in primary and revision hip arthroplasty in India
Get Premium Research Report at: https://www.businessmarketinsights.com/buy/BMIPUB00031715
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact us:
- If you have any questions about this report or would like further information, please contact us:
- Contact person: Ankit Mathur
- Email: sales@businessmarketinsights.com
- Phone: +16467917070
